This book provides an overview of the molecular aspects and pathogenesis
of haematologic malignancies and available targeted therapies and immune
therapeutic approaches in each type of the disease. Active clinical
trials for each product are also collected and adverse events associated
with each medicine are also discussed in detail. It should be noted that
therapeutic approaches in haematologic malignancies are among the
fast-paced study fields in medicine and the approval of each medicinal
product and the indications are subject to change.